Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$887K Buy
392,267
+24,824
+7% +$61.8K ﹤0.01% 2992
2026
Q1
$599K Buy
367,443
+66,591
+22% +$94.9K ﹤0.01% 2771
2025
Q4
$490K Sell
300,852
-619,270
-67% -$1.26M ﹤0.01% 2880
2025
Q3
$2.25M Buy
920,122
+619,270
+206% +$1.69M ﹤0.01% 2260
2025
Q2
$734K Sell
300,852
-947,411
-76% -$2.22M ﹤0.01% 2743
2025
Q1
$3.36M Sell
1,248,263
-564,082
-31% -$2.19M ﹤0.01% 2120
2024
Q4
$8.64M Buy
1,812,345
+283,760
+19% +$1.17M ﹤0.01% 1671
2024
Q3
$4.71M Sell
1,528,585
-329,437
-18% -$1.02M ﹤0.01% 2018
2024
Q2
$5.76M Buy
1,858,022
+214,508
+13% +$689K ﹤0.01% 1873
2024
Q1
$5.74M Sell
1,643,514
-399,559
-20% -$1.26M ﹤0.01% 1915
2023
Q4
$6.23M Buy
2,043,073
+7,891
+0.4% +$17K ﹤0.01% 1857
2023
Q3
$3.85M Buy
2,035,182
+233,455
+13% +$546K ﹤0.01% 1999
2023
Q2
$5.04M Buy
1,801,727
+137,425
+8% +$444K ﹤0.01% 1906
2023
Q1
$6.89M Buy
1,664,302
+83,214
+5% +$436K ﹤0.01% 1707
2022
Q4
$7.37M Buy
1,581,088
+174,311
+12% +$956K ﹤0.01% 1684
2022
Q3
$8.53M Buy
1,406,777
+230,600
+20% +$1.85M ﹤0.01% 1579
2022
Q2
$12.3M Buy
1,176,177
+357,391
+44% +$4.48M ﹤0.01% 1382
2022
Q1
$16.4M Buy
818,786
+316,701
+63% +$6.56M 0.01% 1313
2021
Q4
$15.2M Buy
502,085
+70,646
+16% +$2.32M ﹤0.01% 1412
2021
Q3
$11M Sell
431,439
-25,003
-5% -$592K ﹤0.01% 1708
2021
Q2
$10.3M Sell
456,442
-113,696
-20% -$2.46M ﹤0.01% 1843
2021
Q1
$13.1M Buy
570,138
+322,793
+131% +$7.55M ﹤0.01% 1630
2020
Q4
$5.4M Buy
247,345
+18,394
+8% +$303K ﹤0.01% 2033
2020
Q3
$2.69M Buy
228,951
+28,589
+14% +$356K ﹤0.01% 2232
2020
Q2
$2.28M Sell
200,362
-1,706
-0.8% -$19.3K ﹤0.01% 2279
2020
Q1
$2.25M Sell
202,068
-18
-0% -$252 ﹤0.01% 2134
2019
Q4
$3.23M Buy
202,086
+16,962
+9% +$251K ﹤0.01% 2217
2019
Q3
$2.54M Sell
185,124
-967
-0.5% -$15.2K ﹤0.01% 2301
2019
Q2
$3.43M Buy
+186,091
New +$3.59M ﹤0.01% 2180

Other funds holding CDXS

Nuveen's CDXS Position: Q2 2026 in Review

Nuveen increased its Codexis (CDXS) stake by 6.8% in Q2 2026, buying an estimated $61.8K and bringing the position to 392,267 shares worth $887K. The position accounts for ﹤0.01% of the portfolio, ranked #2992.

Nuveen first reported a position in CDXS in Q2 2019 and has held it in 29 quarters since. The position peaked at $16.4M in Q1 2022. 149 funds tracked by Wall St. Rank hold CDXS as of Q2 2026.

  • Nuveen held 392,267 shares of Codexis worth $887K as of Q2 2026.
  • Nuveen bought 24,824 Codexis shares in Q2 2026, an estimated $61.8K.
  • Codexis made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2992 holding.
  • Nuveen first reported a position in Codexis in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Codexis position peaked at $16.4M in Q1 2022.
  • 149 funds tracked by Wall St. Rank held Codexis as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.